Rituximab is effective as first line therapy in the management of steroid sensitive, but dependent/relapsing adult Nephrotic syndrome
Nephrology (Carlton)
.
2017 Sep;22(9):731-732.
doi: 10.1111/nep.12924.
Authors
Indu R Rao
1
,
Siva Tez Pinnamaneni
1
,
Minz Ranjana
2
,
Nada Ritambhra
3
,
Kumar Vivek
2
,
Rathi Manish
1
,
Harbir S Kohli
1
,
Vivekanand V Jha
4
,
Krishan Gupta
1
,
Ramachandran Raja
1
Affiliations
1
Department of Nephrology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
2
Department of Immunopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
3
Department of Pathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
4
Professor of Nephrology, George Institute for Global Health, New Delhi, India and University of Oxford, Oxford, UK.
PMID:
28792127
DOI:
10.1111/nep.12924
No abstract available
Publication types
Letter
MeSH terms
Adolescent
Adrenal Cortex Hormones / therapeutic use*
Adult
Female
Humans
Male
Middle Aged
Nephrotic Syndrome / drug therapy*
Recurrence
Rituximab / therapeutic use*
Substances
Adrenal Cortex Hormones
Rituximab